159 related articles for article (PubMed ID: 2529633)
1. [Enoximone as an alternative to mechanical circulatory support prior to heart transplantation].
Schmid ER; Zollinger A; Turina M; Dieterich HA
Schweiz Med Wochenschr; 1989 Sep; 119(36):1231-6. PubMed ID: 2529633
[TBL] [Abstract][Full Text] [Related]
2. [Enoximone as pharmacologic "bridging" to heart transplantation].
Friedel N; Teebken M; Lemme A; Schüler S; Hetzer R
Z Kardiol; 1991; 80 Suppl 4():27-33. PubMed ID: 1833894
[TBL] [Abstract][Full Text] [Related]
3. Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors.
Lee HR; Hershberger RE; Port JD; Rasmussen R; Renlund DG; O'Connell JB; Gilbert EM; Mealey PC; Volkman K; Menlove R
J Thorac Cardiovasc Surg; 1991 Aug; 102(2):246-58. PubMed ID: 1650867
[TBL] [Abstract][Full Text] [Related]
4. [Enoximone and the therapeutic strategy in patients awaiting emergency cardiac graft].
Dubois-Randé JL; Loisance D; Duval-Moulin AM; Deleuze P; Lellouche D; Tavolaro O; Hittinger L; Benvenuti C; Merlet P; Brun D
Arch Mal Coeur Vaiss; 1989; 82(8):1433-8. PubMed ID: 2529834
[TBL] [Abstract][Full Text] [Related]
5. [The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
Saborowski F; Peters P; Schneider M
Z Kardiol; 1991; 80 Suppl 4():63-7. PubMed ID: 1833900
[TBL] [Abstract][Full Text] [Related]
6. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure.
Weber KT; Janicki JS; Jain MC
J Heart Transplant; 1986; 5(2):105-12. PubMed ID: 2956397
[TBL] [Abstract][Full Text] [Related]
7. [Effects of R80122. The influence of a new phosphodiesterase inhibitor on global and intestinal hemodynamics in coronary surgery patients].
Lange H; Stephan H; Autschbach R; Lueerssen K; Zielmann S; Sonntag H
Anaesthesist; 1992 Aug; 41(8):474-80. PubMed ID: 1524159
[TBL] [Abstract][Full Text] [Related]
8. [Oral enoximone therapy as a therapeutic bridging before heart transplantation].
Zeplin HE; Stegmann T; Fell JJ; Dressler HT; Dieterich HA
Z Kardiol; 1990 Nov; 79(11):753-7. PubMed ID: 2148996
[TBL] [Abstract][Full Text] [Related]
9. [Vasodilatation and positive inotropic effect of the phosphodiesterase inhibitor enoximone].
Holubarsch C; Hasenfuss G; Thierfelder L; Heiss HW; Just H
Z Kardiol; 1991; 80 Suppl 4():35-40. PubMed ID: 1833895
[TBL] [Abstract][Full Text] [Related]
10. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
Mitrovic V; Neuzner J; Opper H; Thormann J; Schlepper M
Z Kardiol; 1994; 83 Suppl 2():37-48. PubMed ID: 8091823
[TBL] [Abstract][Full Text] [Related]
11. [Enoximone--clinical experiences in heart surgery].
Krüger AD; Francke A; Emmrich K
Anaesthesiol Reanim; 1996; 21(3):60-8. PubMed ID: 8766397
[TBL] [Abstract][Full Text] [Related]
12. Enoximone as a bridge to heart transplantation: the Utah experience.
O'Connell JB; Gilbert EM; Renlund DG; Bristow MR
J Heart Lung Transplant; 1991; 10(3):477-81. PubMed ID: 1830222
[TBL] [Abstract][Full Text] [Related]
13. [Enoximone, a new phosphodiesterase inhibitor: the spectrum of applications during heart surgery--a comparison with dobutamine].
Boldt J; Kling D; Schuhmann E; Scheld HH; Hempelmann G
Herz; 1988 Oct; 13(5):335-42. PubMed ID: 2972597
[TBL] [Abstract][Full Text] [Related]
14. [Use of a new inotropic agent, enoximone, in heart surgery].
Gomar C; Fita G; Pomar JL; Valero R; Mulet J; Nalda MA
Rev Esp Anestesiol Reanim; 1991; 38(2):121-6. PubMed ID: 1678896
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacotherapy of severe heart failure with inodilators--new approaches].
Baumann G; Hader O
Z Kardiol; 1996; 85 Suppl 4():9-19. PubMed ID: 9027110
[TBL] [Abstract][Full Text] [Related]
16. Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method.
Installe E; De Coster P; Gonzalez M; Brichant C; Lessire H; Cauwe F
Eur Heart J; 1991 Sep; 12(9):985-93. PubMed ID: 1834466
[TBL] [Abstract][Full Text] [Related]
17. Present use of positive inotropic drugs in heart failure.
Schlepper M; Thormann J; Kremer P; Mitrovic V; Kramer W
J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S9-19. PubMed ID: 2480492
[TBL] [Abstract][Full Text] [Related]
18. [Enoximone and pediatric heart surgery].
Jayais P; Mauriat P; Pouard P; Journois D
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():109-17. PubMed ID: 2147826
[TBL] [Abstract][Full Text] [Related]
19. The role of enoximone in the treatment of cardiogenic shock.
Vincent JL; Léon M; Berré J
Cardiology; 1990; 77 Suppl 3():21-6; discussion 27-33. PubMed ID: 2176130
[TBL] [Abstract][Full Text] [Related]
20. Beneficial haemodynamic effects of enoximone in cardiac transplant candidates awaiting a suitable donor.
Vulser C; Guillemain R; Amrein C; Trinquier R; Farge D; Dreyfus G; Couetil JP; Carpentier A; Cousin MT
J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):11. PubMed ID: 2535300
[No Abstract] [Full Text] [Related]
[Next] [New Search]
